BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16432775)

  • 41. [Fabry disease. An interdisciplinary challenge].
    Cybulla M; Neumann HP
    Dtsch Med Wochenschr; 2007 Oct; 132(43):2271-7. PubMed ID: 17940933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.
    Nance CS; Klein CJ; Banikazemi M; Dikman SH; Phelps RG; McArthur JC; Rodriguez M; Desnick RJ
    Arch Neurol; 2006 Mar; 63(3):453-7. PubMed ID: 16533976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fabry disease--a special therapy now available].
    Rasmussen AK; Mersebach H; Hasholt L; Rosenberg KM; Sørensen SA; Feldt-Rasmussen UF
    Ugeskr Laeger; 2001 Sep; 163(39):5382. PubMed ID: 11590956
    [No Abstract]   [Full Text] [Related]  

  • 44. Amelioration of white-matter lesions in a patient with Fabry disease.
    Yamadera M; Yokoe M; Beck G; Mihara M; Oe H; Yamamoto Y; Sakoda S
    J Neurol Sci; 2009 Apr; 279(1-2):118-20. PubMed ID: 19185318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fabry disease: perspectives of urinary proteomics.
    Cuccurullo M; Beneduci A; Anand S; Mignani R; Cianciaruso B; Bachi A; Capasso G
    J Nephrol; 2010; 23 Suppl 16():S199-212. PubMed ID: 21170881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac challenges in patients with Fabry disease.
    Weidemann F; Linhart A; Monserrat L; Strotmann J
    Int J Cardiol; 2010 May; 141(1):3-10. PubMed ID: 19720409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel alpha-galactosidase a mutant (M42L) identified in a renal variant of Fabry disease.
    Rosenthal D; Lien YH; Lager D; Lai LW; Shang S; Leung N; Fervenza FC
    Am J Kidney Dis; 2004 Nov; 44(5):e85-9. PubMed ID: 15492942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
    Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
    Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
    Brokalaki EI; Hentschke M; Grabbe S; Jansen T
    Eur J Med Res; 2006 Jul; 11(7):306-8. PubMed ID: 16899426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fabry disease.
    Germain DP
    Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry.
    Kitagawa T; Ishige N; Suzuki K; Owada M; Ohashi T; Kobayashi M; Eto Y; Tanaka A; Mills K; Winchester B; Keutzer J
    Mol Genet Metab; 2005 Jul; 85(3):196-202. PubMed ID: 15979031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review].
    Müller MJ; Müller KM; Dascalescu A; Whybra C; Baron K; Scheurich A; Mann K; Beck M; Schmidt LG; Fellgiebel A
    Fortschr Neurol Psychiatr; 2005 Nov; 73(11):687-93. PubMed ID: 16283613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
    Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
    Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fabry disease.
    Toyooka K
    Handb Clin Neurol; 2013; 115():629-42. PubMed ID: 23931807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The neurological manifestations of Fabry disease. A review].
    Firsov KV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9):98-105. PubMed ID: 27735906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lysosome-associated protein 1 (LAMP-1) and lysosome-associated protein 2 (LAMP-2) in a larger family carrier of Fabry disease.
    Pereira EM; do Monte SJ; do Nascimento FF; de Castro JA; Sousa JL; Filho HC; da Silva RN; Labilloy A; Monte Neto JT; da Silva AS
    Gene; 2014 Feb; 536(1):118-22. PubMed ID: 24334114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diagnostic problems in a 17-year-old patient with gastrointestinal manifestations of Fabry disease].
    Buda P; Wieteska-Klimczak A; Ksiazyk J; Smorczewska-Kiljan A; Gietka P; Czartoryska B; Tylki-Szymańska A
    Med Wieku Rozwoj; 2011; 15(1):69-72. PubMed ID: 21786514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Early diagnosis of Fabry disease in children].
    Genoni G; Demarchi I; Bellone S; Petri A; Settanni F; Dondi E; Negro M; Cortese L; Prodam F; Bona G
    Minerva Pediatr; 2011 Oct; 63(5):425-30. PubMed ID: 21946453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal transplantation between siblings with unrecognized Fabry disease.
    Taneda S; Honda K; Nakajima I; Huchinoue S; Oda H
    Transplant Proc; 2013; 45(1):115-8. PubMed ID: 23375284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fabry disease--a diagnostic and therapeutic problem.
    Strujić BJ; Jeren T
    Ren Fail; 2005; 27(6):783-6. PubMed ID: 16350834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.